Literature DB >> 9869096

Apoptosis of T lymphocytes in liver and/or small bowel allografts during tolerance induction.

D Meyer1, S Baumgardt, S Loeffeler, S Czub, C Otto, H J Gassel, W Timmermann, A Thiede, K Ulrichs.   

Abstract

BACKGROUND: Apoptosis of parenchymal cells has been described during allograft rejection. Immunologically privileged tissue in the mouse has been found to prevent rejection by initiating apoptosis of infiltrating lymphocytes. The aim of this study was to investigate whether apoptosis may play a role in T-cell regulation during rejection and subsequent tolerance induction after liver transplantation (LTx) and combined liver/small bowel transplantation (LSBTx).
METHODS: LTx and LSBTx (Brown Norway-->Lewis) were performed without immunosuppression. Cell migration, activation, and apoptosis were investigated by means of sequential histology, immunohistochemistry, and the terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling assay. Donor (Brown Norway) and third-party (Dark Agouti) cardiac allografts were transplanted into LSBTx recipients to determine specific tolerance.
RESULTS: Transient acute cellular rejection occurred after LTx and LSBTx and was followed by specific tolerance. The kinetics of apoptosis were similar in liver allografts after LTx and LSBTx, but differed from the processes in small bowel allografts after LSBTx. Apoptosis of parenchymal cells in the grafted livers correlated directly with interleukin-2 receptor expression of the infiltrating T cells. During the late phase of rejection, a peak of apoptosis in the lymphocyte infiltrate was demonstrated, characterized as predominantly apoptotic CD8+ T lymphocytes.
CONCLUSIONS: These results demonstrate that specific tolerance is achieved in both LTx and LSBTx after a transient rejection crisis. Apoptosis is involved in graft rejection and tolerance induction. Activation of T lymphocytes correlates with parenchymal cell apoptosis in the allograft. T-cell inactivation seems to result in apoptosis of cytotoxic T cells and tolerance, which appears to be unique to the liver allograft.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869096     DOI: 10.1097/00007890-199812150-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  New approaches to inducing the death of alloreactive lymphocytes.

Authors:  S M Krams
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 2.  Dendritic cells and immune regulation in the liver.

Authors:  A H Lau; A W Thomson
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

3.  Accelerating the induction of Fas-mediated T cell apoptosis: a strategy for transplant tolerance?

Authors:  H P Carroll; S Ali; J A Kirby
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  Combined small bowel and reduced auxiliary liver transplantation: case report.

Authors:  Wei-Jie Zhang; Dun-Gui Liu; Qi-Fa Ye; Bo Sha; Fan-Jun Zhen; Hui Guo; Sui-Sheng Xia
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

5.  Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.

Authors:  N Ichikawa; A J Demetris; T E Starzl; Q Ye; T Okuda; H J Chun; K Liu; Y M Kim; N Murase
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

6.  Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.

Authors:  L Lu; W Li; C Zhong; S Qian; J J Fung; A W Thomson; T E Starzl
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

7.  Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway.

Authors:  Ronald Charles; Hong-Shiue Chou; Lianfu Wang; John J Fung; Lina Lu; Shiguang Qian
Journal:  Transplantation       Date:  2013-07-15       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.